These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18350285)

  • 1. A reversible coma after oxaliplatin administration suggests a pathogenetic role of electrolyte imbalance.
    Basso M; Cassano A; Modoni A; Spada D; Trigila N; Quirino M; Schinzari G; Barone C
    Eur J Clin Pharmacol; 2008 Jul; 64(7):739-41. PubMed ID: 18350285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypocalcemic hypomagnesemic coma after carboplatin].
    Beuzeboc P; Deygere H; Boccaccio F; Christoforov B
    Presse Med; 1989 Sep 2-9; 18(27):1343-4. PubMed ID: 2529502
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohemolytic anemia following oxaliplatin administration.
    Garufi C; Vaglio S; Brienza S; Conti L; D'Attino RM; Girelli G; Terzoli E
    Ann Oncol; 2000 Apr; 11(4):497. PubMed ID: 10847475
    [No Abstract]   [Full Text] [Related]  

  • 4. Anaphylaxis after oxaliplatin.
    Médioni J; Coulon MA; Morere JF; Hennebelle F; Piperno-Neumann S; Breau JL
    Ann Oncol; 1999 May; 10(5):610. PubMed ID: 10416017
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaliplatin-induced neuropathy: a tale of two electrolytes.
    Babiker HM; Green MR; Nelson MA; Elquza E
    Support Care Cancer; 2015 Jun; 23(6):1483-5. PubMed ID: 25801447
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal tubular acidosis due to oxaliplatin.
    Linch M; Cunningham D; Mingo O; Stiles A; Farquhar-Smith WP
    Ann Oncol; 2007 Apr; 18(4):805-6. PubMed ID: 17389529
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversible palpebral ptosis following oxaliplatin infusion.
    La Verde N; Garassino MC; Spinelli G; Scanni A; Sburlati P; Farina G; Labianca R
    Dig Liver Dis; 2007 Nov; 39(11):1041. PubMed ID: 17913604
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin.
    Pinedo DM; Shah-Khan F; Shah PC
    J Clin Oncol; 2007 Nov; 25(33):5320-1. PubMed ID: 18024878
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe anaphylactic reactions to oxaliplatin.
    Tournigand C; Maindrault-Goebel F; Louvet C; de Gramont A; Krulik M
    Eur J Cancer; 1998 Jul; 34(8):1297-8. PubMed ID: 9849497
    [No Abstract]   [Full Text] [Related]  

  • 10. Sudden-onset thrombocytopenia with oxaliplatin.
    Dold FG; Mitchell EP
    Ann Intern Med; 2003 Jul; 139(2):E156. PubMed ID: 12859182
    [No Abstract]   [Full Text] [Related]  

  • 11. Lessons learned from hyponatremia associated with hyperthermic intraperitoneal chemoperfusion with oxaliplatin.
    Nguyen MK
    Perit Dial Int; 2008; 28(1):32-4. PubMed ID: 18178945
    [No Abstract]   [Full Text] [Related]  

  • 12. Ocular changes with oxaliplatin.
    O'Dea D; Handy CM; Wexler A
    Clin J Oncol Nurs; 2006 Apr; 10(2):227-9. PubMed ID: 16708705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report of oxaliplatin extravasation.
    Foo KF; Michael M; Toner G; Zalcberg J
    Ann Oncol; 2003 Jun; 14(6):961-2. PubMed ID: 12796037
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute, generalised but transient muscle cramping and weakness shortly after first oxaliplatin infusion.
    Krexner E; Stickler A; Prainer C; Finsterer J
    Med Oncol; 2012 Dec; 29(5):3592-3. PubMed ID: 22669568
    [No Abstract]   [Full Text] [Related]  

  • 15. Serious delayed hypersensitivity reaction to oxaliplatin.
    de Vries RS; Mattijssen EJ; van Sorge AA
    Ann Oncol; 2006 Nov; 17(11):1723-4. PubMed ID: 16757568
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxaliplatin-induced haemolytic anaemia.
    Desrame J; Broustet H; Darodes de Tailly P; Girard D; Saissy JM
    Lancet; 1999 Oct; 354(9185):1179-80. PubMed ID: 10513718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous administration of amifostine: a promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy.
    Penz M; Kornek GV; Raderer M; Ulrich-Pur H; Fiebiger W; Scheithauer W
    Ann Oncol; 2001 Mar; 12(3):421-2. PubMed ID: 11332158
    [No Abstract]   [Full Text] [Related]  

  • 18. Reaction after oxaliplatin--prevention with corticosteroids?
    Stahl M; Köster W; Wilke H
    Ann Oncol; 2001 Jun; 12(6):874. PubMed ID: 11484969
    [No Abstract]   [Full Text] [Related]  

  • 19. [Genetic backgrounds of peripheral neuropathy induced by oxaliplatin].
    Mitsuma A; Ando Y
    Nihon Yakurigaku Zasshi; 2013 Feb; 141(2):62-5. PubMed ID: 23391543
    [No Abstract]   [Full Text] [Related]  

  • 20. Idiosyncratic reaction after oxaliplatin: circumvention by use of a continuous infusional administration schedule.
    Schüll B; Kornek GV; Scheithauer W
    Ann Oncol; 2001 Nov; 12(11):1653-4. PubMed ID: 11822769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.